This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hochgeschwender, U. Articles by Brennan, M. B. Search for Related Content PubMed PubMed Citation Articles by Hochgeschwender, U. Articles by Brennan, M. B.

Altered Glucose Homeostasis in Proopiomelanocortin-Null Mouse Mutants Lacking Central and Peripheral Melanocortin

Oklahoma Medical Research Foundation (U.H., P.R., S.B.), Oklahoma City, Oklahoma 73104; and Eleanor Roosevelt Institute (J.L.C., M.B.B.), University of Denver, Denver, Colorado 80206

Address all correspondence and requests for reprints to: Dr. Ute Hochgeschwender, Oklahoma Medical Research Foundation, 825 NE 13th Street, MS 48, Oklahoma City, Oklahoma 73104. E-mail: ute-hochgeschwender{at}omrf.ouhsc.edu. Or to: Dr. Miles B. Brennan, Eleanor Roosevelt Institute, University of Denver, 1899 Gaylord Street, Denver, Colorado 80206. E-mail: mbrenna3{at}du.edu.

Prolonged obesity frequently leads to insulin resistance and, eventually, to diabetes. This relationship reflects the integration of fat stores and carbohydrate metabolism and the coordination of central nervous system functions, e.g. appetite, and peripheral metabolism. Recent work suggests that the melanocortin system is involved in this integration; specifically, central administration of melanocyte-stimulating hormone (MSH) decreases, whereas lack of central MSH signaling increases, peripheral insulin resistance. Here we asked whether MSH acting in the periphery has a complementary role in insulin resistance. We tested this in a mouse model where the proopiomelanocortin (POMC) gene encoding all of the melanocortins has been genetically deleted. The homozygous POMC-null mouse lacks central as well as peripheral MSH signaling; in addition, it lacks adrenal glands and thus is devoid of corticosterone and epinephrine. Here we report that homozygous POMC mutants have normal serum levels of insulin, normal fasting levels of glucose, and normal clearance of glucose in glucose tolerance tests. Thus, insulin production and sensitivity and glucose uptake in peripheral tissues are functioning normally. However, we found a striking inability of the homozygous POMC mutants to recover from insulin-induced hypoglycemia. This defect was in the glucagon-mediated counterregulatory response. Both peripheral administration of an MSH analog and supplementation with corticosterone alleviated the hypoglycemia after insulin challenge, but did not make the obese POMC mutant mice diabetic. We conclude that, similar to the regulation of body weight homeostasis, the regulation of glucose homeostasis requires the integration of both central and peripheral melanocortin signaling systems.

This article has been cited by other articles:

				A. P. Coll, B. G. Challis, M. Lopez, S. Piper, G. S.H. Yeo, and S. O'Rahilly Proopiomelanocortin-Deficient Mice Are Hypersensitive to the Adverse Metabolic Effects of Glucocorticoids Diabetes, August 1, 2005; 54(8): 2269 - 2276. [Abstract] [Full Text] [PDF]

				G. Cai, S. A Cole, R. A Bastarrachea-Sosa, J. W MacCluer, J. Blangero, and A. G Comuzzie Quantitative trait locus determining dietary macronutrient intakes is located on human chromosome 2p22 Am. J. Clinical Nutrition, November 1, 2004; 80(5): 1410 - 1414. [Abstract] [Full Text] [PDF]